Share Name Share Symbol Market Type Share ISIN Share Description
BTG Plc LSE:BTG London Ordinary Share GB0001001592 ORD 10P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -1.50p -0.22% 680.50p 679.50p 680.50p 681.50p 669.50p 680.00p 809,182.00 16:29:52
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Support Services 447.5 57.5 15.8 43.1 2,620.79

BTG Share Discussion Threads

Showing 4526 to 4549 of 4550 messages
Chat Pages: 182  181  180  179  178  177  176  175  174  173  172  171  Older
DateSubjectAuthorDiscuss
28/4/2017
07:47
You must be right nervous novice . May be better taking an average of the three which is 37.66. Still high for a non divi company with a track record of not delivering growth as forecast. Hopefully that is about to change.
bargainbob
28/4/2017
01:57
well it shows as 30 on HL
nervousnovice
27/4/2017
23:41
43 on today's listing on the financials link.
fhmktg
27/4/2017
18:23
Not 40x PE it is 30 and that will change substantively when the results are out.
nervousnovice
27/4/2017
17:44
No divi , 40 times PE , not a lot of value .
bargainbob
27/4/2017
16:36
Bargain bob , rising turover , rising profits per coming down , dollar doing well , this is good for steady rise
doctor 69
27/4/2017
16:20
looks good for a close above the resistance line today
nervousnovice
27/4/2017
07:35
Hope it not just Woodford , pretty sure he is behind the large swings in BTG every year. Would love it to be other large shareholders . From what I can see not a lot of value for anyone buying at the moment , unless a takeover is on the cards .
bargainbob
27/4/2017
01:09
Woodford bought Allied Minds and look what happened there, I hope he isn't bringing the kiss of death! Seems to have broken through the resistance line hopefully it can hold out and move higher tomorrow.
nervousnovice
26/4/2017
23:28
Rns 13/4/17 stake now over 10% Close relationship with Louise Whatch out for more holdings updates.
dp1umb
26/4/2017
19:53
Could be results leakage and shorts closing perhaps
cyman
26/4/2017
19:23
Dp is that a guess or you seen it somewhere?
cyman
26/4/2017
19:23
DP1 Is that speculation or fact?
nervousnovice
26/4/2017
17:22
No Woodford buying a bigger stake!
dp1umb
26/4/2017
17:13
I bought this more years ago then I can remember , something is very much up. Takeover at last ?
bargainbob
26/4/2017
15:39
Bought in last week and today looks interesting
doctor 69
26/4/2017
14:27
I bought this a couple of weeks ago expecting the downward trend in place since January 2015 to reverse. A good start, up 9%. We are approaching the all important resistance line, I expect a breakout before or on the results in May, they have indicated results will be at the upper end or above forecasts continuing the growth pattern.
nervousnovice
26/4/2017
13:41
I love this stock and all who sail in her.Assisted by some barbed criticism here,I've had a damascene experience!
steeplejack
26/4/2017
13:08
wow , bit of a kick today.
bargainbob
25/4/2017
12:29
Do not know much , looks like a useful tool to influence enhanced treatment for patients . Firstly great if it helps patients with this terrible illness , seconadary an important step if BTG can manage drugs and other treaments in an efficient manner . I suspect this will led to other bolt ons in this sector , may even led to partnerships . A win Win .
bargainbob
25/4/2017
12:03
Any thoughts as to how Oncoverse will enhance the btg group?
fhmktg
24/4/2017
16:30
Impressive turnaround.
revoman
24/4/2017
12:45
Netscientific announces that BTG plc has purchased Wanda's shares in OncoVerse for next stage of development London, UK - 24 April 2017 - NetScientific Plc (AIM: NSCI, "NetScientific", "the Group"), the transatlantic healthcare IP commercialisation Group, announces that its portfolio company Wanda has sold its holding in OncoVerse LLC ('OncoVerse' or 'the Company') to BTG plc ('BTG') for an undisclosed amount. The sale represents a strong return on NetScientific's initial investment and a successful exit from the first downstream application from Wanda, validating Wanda's superior ability to provide support for clinicians. OncoVerse is a digital health platform designed to allow cancer patients' care teams to collaborate and allow clinicians across all disciplines to work together to determine the most effective treatment plan for their patients. OncoVerse was initially conceived by a Dignity Health physician and two administrators, who wanted a tool to improve team collaboration, especially when evaluating complex cancer cases and determining the appropriate treatment plans for patients. Dignity Health, one of the nation's largest health care systems, prototyped and tested the platform internally and then partnered with Wanda to further develop the software. Dignity Health has also been a co-investor in the joint venture since the platform's inception and will continue to be a shareholder alongside BTG. NetScientific's equity in OncoVerse comes from its majority shareholding in Wanda. Commenting on the news, François R. Martelet, Chief Executive Officer of NetScientific and Chairman of Wanda, said: "We believe the OncoVerse platform will become a leading tool in the management of cancer patients and we are proud to have been involved in helping bring it to maturity. The sale of the equity to BTG represents a strong return on NetScientific's initial investment, and underscores Wanda's unique expertise in creating tools which can support informed treatment decisions. We are continuing to work with Wanda to support the company in the development of remote health management tools and sophisticated data analysis and to identify other promising opportunities to maximise investment returns from the technology." Foad Dabiri, CEO of Wanda, commented: "I am very proud of the team at Wanda for creating such a valuable product, in collaboration with Dignity Health, which helps improve quality of care for cancer patients. BTG's expertise and partnership will enable a strong path forward for Oncoverse and its mission. We at Wanda will continue focusing on building modern and innovative clinical solutions to enhance management of care for patients." - Ends -
bargainbob
24/4/2017
12:27
Strange that BTG did not announce the Oncoverse purchase. I wonder how much they paid. On the face of it it's an advantageous action. It'll be nice though if the bad guys were to stop messing about with the share price ... It probably won't be long now.
muffmitz
Chat Pages: 182  181  180  179  178  177  176  175  174  173  172  171  Older
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:33 V: D:20170428 15:57:50